Literature DB >> 17198820

Intermittent warm blood cardioplegia in the surgical treatment of congenital heart disease: clinical experience with 1400 cases.

Yves Durandy1, Sylvie Hulin.   

Abstract

OBJECTIVE: To analyze our experience with warm blood cardioplegia in pediatric cardiac surgery.
METHODS: We used intermittent (every 15 minutes after initial injection) warm blood cardioplegia in the treatment of 1400 patients. Results were retrospectively compared with those of 950 patients treated with cold blood cardioplegia. The following parameters were analyzed: (1) hydric balance of cardioplegic solution; (2) resumption of rhythm after aortic crossclamp removal; (3) duration of mechanical ventilation, intensive care unit stay, and incidence of mortality in 4 selected diagnostic groups: ventricular septal defect, tetralogy of Fallot, atrioventricular septal defect, and transposition of the great arteries. These 4 groups, treated with warm or cold cardioplegia, were comparable with regard to age, weight, crossclamp times, and percent with Down syndrome; (4) troponin level at 12 hours after aortic crossclamping; and (5) duration of intensive care unit stay for the 1400 patients.
RESULTS: Warm versus cold cardioplegia: negligible fluid addition with warm cardioplegia compared with blood loss/prime dilution induced by cold cardioplegia; spontaneous resumption of sinus rhythm in 99% versus 77% of patients (P < .001); shorter duration of ventilatory support in each diagnostic group, significant in all cases; smaller increase in troponin in each group (P < .05). Incidence of early death was not different in the 2 groups. For the whole group, duration of the intensive care unit stay was less than 48 hours in 86% versus 75% (P < .001).
CONCLUSION: In our experience, normothermic cardioplegia has not generated any particular inconvenience and its use was contemporary, with improved outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198820     DOI: 10.1016/j.jtcvs.2006.10.004

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

Review 1.  Is there a rationale for short cardioplegia re-dosing intervals?

Authors:  Yves D Durandy
Journal:  World J Cardiol       Date:  2015-10-26

Review 2.  Blood Versus Crystalloid Cardioplegia in Pediatric Cardiac Surgery: A Systematic Review and Meta-analysis.

Authors:  Konstantinos S Mylonas; Aspasia Tzani; Panagiotis Metaxas; Dimitrios Schizas; Vasileios Boikou; Konstantinos P Economopoulos
Journal:  Pediatr Cardiol       Date:  2017-09-25       Impact factor: 1.655

3.  Perfusionist strategies for blood conservation in pediatric cardiac surgery.

Authors:  Yves Durandy
Journal:  World J Cardiol       Date:  2010-02-26

Review 4.  Accelerated Cardiac Aging in Patients With Congenital Heart Disease.

Authors:  Dominga Iacobazzi; Valeria Vincenza Alvino; Massimo Caputo; Paolo Madeddu
Journal:  Front Cardiovasc Med       Date:  2022-05-26

5.  Normothermic versus hypothermic cardiopulmonary bypass in children undergoing open heart surgery (thermic-2): study protocol for a randomized controlled trial.

Authors:  Sarah Baos; Karen Sheehan; Lucy Culliford; Katie Pike; Lucy Ellis; Andrew J Parry; Serban Stoica; Mohamed T Ghorbel; Massimo Caputo; Chris A Rogers
Journal:  JMIR Res Protoc       Date:  2015-05-25

6.  Normothermic versus hypothermic cardiopulmonary bypass in low-risk paediatric heart surgery: a randomised controlled trial.

Authors:  Massimo Caputo; Katie Pike; Sarah Baos; Karen Sheehan; Kathleen Selway; Lucy Ellis; Serban Stoica; Andrew Parry; Gemma Clayton; Lucy Culliford; Gianni D Angelini; Ragini Pandey; Chris A Rogers
Journal:  Heart       Date:  2018-10-15       Impact factor: 5.994

7.  Rationale for Implementation of Warm Cardiac Surgery in Pediatrics.

Authors:  Yves Durandy
Journal:  Front Pediatr       Date:  2016-05-06       Impact factor: 3.418

8.  Intermittent antegrade warm-blood versus cold-blood cardioplegia in children undergoing open heart surgery: a protocol for a randomised controlled study (Thermic-3).

Authors:  Rachael Heys; Serban Stoica; Gianni Angelini; Richard Beringer; Rebecca Evans; Mohamed Ghorbel; William Lansdowne; Andrew Parry; Guido Pieles; Barnaby Reeves; Chris Rogers; Rohit Saxena; Karen Sheehan; Stella Smith; Terrie Walker-Smith; Robert Mr Tulloh; Massimo Caputo
Journal:  BMJ Open       Date:  2020-10-14       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.